new heart guidelines

some interesting news.
07:21 02Sep2005 DJ MARKET TALK: New Heart Guidelines May Benefit Thoratec
07:21 02Sep2005 DJ MARKET TALK: New Heart Guidelines May Benefit Thoratec

DJ MARKET TALK: New Heart Guidelines May Benefit Thoratec

Edited by John Shipman
Of DOW JONES NEWSWIRES

(call: 201 938 5171; e-mail:[email protected])

MARKET TALK can be found using N/DJMT

10:21 (Dow Jones) Thoratec (THOR) shares on a roll this year, up nearly 60%. And
the company could get another boost from new heart failure guidelines released by
the American College of Cardiology and the American Heart Association, says
analyst Jason Mills of First Albany. New guidelines recommend use of a
ventricular assist device (VAD) system (which THOR makes) as destination therapy
(permanent support therapy) for patients with end-stage heart failure that hasn't
responded to treatment. "We believe the new ACC/AHA guidelines...will resonate
with referring cardiologists and lead to higher VAD utilization," Mills writes.
He also sees THOR as a potential M&A target within 18 months. Shares up 0.5% at
$16.53. (DMR)